Wednesday, 22 July 2020

Orthopaedic Implants Market to Witness Exponential Rise in Revenue Share during the Forecast Period (2020-2026)

New Report "Orthopedic implants market size is set to reach USD 6,894.2 million by 2026 growing at a CAGR of 5.1% during the forecast period according to a new study published by Polaris Market Research. The report ‘Orthopedic Implants Market Share, Size, Trends & Industry Analysis Report, By Application (Spinal, Hip, Knee, Dental, Craniomaxillofacial and S.E.T (Sports Medicine, Extremities, and Trauma)) and by Regions, Segment Forecast 2019-2026’ provides a detailed analysis of present market strengths and future market trends.

The prime purpose of orthopedic implants is to support or replace a missing or damaged bone or joint. They come in extremely handy to treat deformities, correct body posture and put straight the normal skeletal function. The market analysis has seen a tectonic shift from traditional surgical procedures to ultra-modern fixations and prosthetics.


Market success of orthopedic Implants is entrenched in a rising geriatric population with an increasing life-span affected by musculoskeletal disorders such as osteoporosis, osteoarthritis and others. Technological innovations also have seen a steady rise in orthopedic medical implants market. Increasing number of joint replacement cases and sport injuries across the globe will catapult market to leading growth.    
Orthopedic Implants Market by Region
The center for health design has predicted elderly population to double in coming years. For instance; Japan and South Korea have a life expectancy of 83.7 years and 82.3 years respectively. Surplus Government investments in medical industry and supportive Government opinions in use of implants have directed massive growth for market in coming years.

Restraints to the market are the high cost of treatments associated with orthopedic implants and restrictive Government policies that hamper market growth. Developing economies have a lot going for successful growth in the industry by way of lucrative opportunities.     

The global orthopedic medical implants market is segmented into product, biomaterial, type and region. Based on product, it is classified into reconstructive joint replacements, spinal implants, dental implants, trauma and craniomaxillofacial, orthobiologics and others. The Reconstructive Joint replacement market is further subdivided into knee, hip and extremities. Spinal Implants branch into spinal fusion devices, non-fusion devices/motion preservation devices and invasive spinal bone stimulators. Dental Implants are classified into root form and plate form. Trauma is categorized into screws, plates, staples and others. Based on type, the market is segmented into knee, hip, wrist and shoulder, dental, spine, ankle and others.


Product type comprising reconstructive joint replacements had peak market share in orthopedic implants market analysis.  Reason being increase in prevalence of osteoporosis and osteoarthritis, inventions in joints replacements and rich investments by key players’ in R&D. Spinal  Orthopedic Implants segment is tipped to lead market growth in forecast period. Key findings suggest that orthobiologics segment is expected to tap profuse market growth with concurrent rise in demand for advanced therapies, requirement of minimally invasive procedures and patient awareness towards orthobiologics.

Increasing investments by Government in healthcare and in doting company with a well-developed healthcare infrastructure add momentum to market in North America and Canada. Asia Pacific     offers key players operating in market a thriving opportunity due to a high population base, high awareness regarding orthopedic implants, surge in healthcare infrastructure and rise in geriatric population. The key players operating in the orthopedics Implants market include Johnson and Johnson, Zimmer Biomet Holdings, Inc., Stryker Corporation and Medtronic PLC among others.

Segmentation of Orthopedic Implants Market is as follows
Orthopedic Implant Application Type Outlook (Revenue USD Millions 2015-2026)
  • Spinal
  • Hip
  • Knee
  • Craniomaxillofacial
  • Dental Orthopedic
  • E.T (Sports Medicine, Extremities, Trauma) Orthopedic
Orthopedic Implants Regional Outlook (Revenue USD Millions 2015-2026)
  • North America
    • US
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Mexico
    • Brazil
  • Middle East and Africa

on No comments:
Labels: , , ,

Cryotherapy Market to Witness Exponential Rise in Revenue Share during the Forecast Period (2020-2026)

The global cryotherapy market size is set to achieve 6.72 billion by 2026 at a CAGR of 9.8% according to a new study published by Polaris Market Research. Cryotherapy is known in medical science as an application of low temperature for treating malignant tissues and malignant tissue damage called lesions. Cryotherapy finds common applications in treating muscle pain, sprains, swelling, soft tissue damage and postoperative swelling.

Cryotherapy known as cryoablation is a non-invasive therapy that is useful in pain reduction, abnormal skin treatment and treating local tumors. Cryosurgery is directing extreme cold to diseased tissues to destroy them. Then, ice pack therapy is administered to an injured area of body. It is for no small reason that cryotherapy devices market is considered the most potent treatment for cancer. Rising incidences of cancer will give growth to phenomenal strides in market. Cryotherapy, also called cryoablation, is a non-invasive therapy used for alleviating pain, treating abnormal skin, and treating localized tumors. It can be administered locally or on whole body. 


cryotherapy market

The key factors driving cryotherapy market include high prevalence of cancer, increasing demand for minimally invasive procedures, technological prowess in cryotherapy equipment and growing popularity in fitness, wellness and beauty industries. Uncertainty over traditional methods still exist because use of argon gas and crypto probes are not definitive standards and have to seek approval by the regulatory body. Safety and effectiveness have a long way to go. Hence lack of clinical evidences is limiting factors to growth of cryotherapy units market.

The key players in Cryotherapy market include CryoConcepts LP, Medtronic plc, Brymill Cryogenci Systems, Cortex Technoologies, Cooper Surgical, Inc., and Zimmer Medizin Systems.

High-risk cryogenic gases and strict regulatory approvals for the gases could be defining restraints for the market. On the other hand, success factors for cryosurgery are that it scores over traditional surgery, marked by few complications, negligible scars, less pain and shorter hospitals stay. These factors will bolster market.


The cryotherapy market in North America and Europe is boosted by increasing demand from athletes and film actors to recover from injury faster and prevent aging. Companies are constantly on the look-out to develop innovative products for cryotherapy in order to gain larger user base in emerging economies such as India, China, and Brazil. North America stands out over other regions with its market domination.


Cryosurgery therapy type segment soars over other types of therapies owing to minimally invasive surgery holding sway. Cryosurgery helps repair damaged tissues without bringing any harm to healthy tissues in the body. Negligible side effects and faster recoveries will bring forth market success during forecast period. A whole-body cryotherapy (WBC) is useful in improving athletes’ performance and reduces his downtime by helping him recover early from muscular injuries and pain.

Oncology dominates market segment with 80% market share. This is due to rising number of patients being targeted by cancer with increasing mortality rates. Cryotherapy is advantageous, more so as it offers a turnaround solution to patients who are non-treatable, non-operable and those who are unresponsive to treatment. Cryotherapy also is used in skin treatment and for treating eye lesions. The uniqueness of the method lies in applying liquid nitrogen using a cotton swab or a spraying device.
on No comments:
Labels: , , , , ,

Plant Based Meat Market Size Research Report With Global and Regional COVID-19 Growth Impact Analysis and Forecast, 2020-2027

The global plant-based meat market size is expected to reach USD 35.4 billion by 2027 according to a new study by Polaris Market Research. Plant meats have ingredients sourced from plants such as soy, to mimicking the texture of animal meat. Current innovations also claim that it offers the same cooking and eating experience as of traditional animal based meat. Few hamburger outlets have introduced plant-based patties, which exactly matches the texture of the beef offered in the same outlet.

Consumers find potential advantages of plant-based foods, on the other side, and equate such items with better health outcomes and higher nutritional value. A 2016 study by Oxford University found that a ‘healthy’ diet (i.e. one that contains less meat) could prevent 5.1 million deaths worldwide by 2050. Meat-free protein products are no longer restricted to the relatively small group of consumers who identify as vegetarian or vegan. For example, 39 per cent of the U.S. citizens are actively using plant originated foods in their diets, and this shift is driven by millennials: 30 per cent eat meat alternatives every day, while 50 per cent eat meat alternatives several times a week.


Plant-Based Meat Market
Get PDF
The global plant-based meat market is driven by growing concern towards animal based meat owing to global narrative that COVID-19 originated from wild animals. The growing vegan population in Europe, consumer awareness towards nutritional benefits, and innovations in food technology coupled with funding support from investment firms. Recently, in June 2020, Veganuary, the UK based non-profit organization introduced Veg Capital, funding solutions plant-based food companies. It will provide fund of around EUR 50,000 to 2,50,000 to the plant-based food startups.

Moreover, strong government intent also pitched the usage of plant-based meat in the forefront. Governments are now beginning to understand the climatic and environmental effects of diets. The expert panel of the review team recommended the inclusion of key material environmental indicators during the most recent revision of the US dietary guidelines in 2015. Denmark is considering proposals for imposing a red meat tax. In 2016, Sweden’s Green Party tabled a motion in the Swedish parliament calling for a climate tax on food.

Market participants in the plant-based meat market include Impossible Foods, V2food, Beyond Meat, Garden Protein International, Zhenmeat, Morningstar Farms, Novameat, Quorn Foods, Amy’s Kitchen, Omnipork, Maple Leaf Foods, Zikooin, The Vegetarian Butcher, Greenwise, Tofurky, Gold & Green Foods, Sunfed, and VBites. are some of the key players operating in the concerned market. They are competing on several factors such as price, product quality, taste, nutritional claims, brand value, advertisement, and promotions.

For Further Insights and Segment-Specific Information, Contact a Market Analyst At : https://www.polarismarketresearch.com/industry-analysis/plant-based-meat-market/speak-to-analyst
on No comments:
Labels: , , ,

U.S. Durable Medical Equipment Market Trends & Leading Players| Industry Size, Growth, Segments, Revenue, Manufacturers & Forecast Research Report

The U.S. Durable Medical Equipment market size is expected to reach USD 76.32 billion by 2026 according to a new study by Polaris Market Research. The medical device manufacturers are developing new and improved equipment based on durability and reliability to improve the quality of life of the patients in need. With growing demand for home healthcare, the adoption of home care equipment is also increasing. Several new organizations are established that are launching and scaling advanced home care models to move primary, acute, and palliative care to the home. There are numerous dynamics that are driving patient’s preference for healthcare settings specifically towards home which in-turn is enhancing the adoption of durable medical equipment across various regions.

The primary factor driving the growth of durable medical equipment market in the U.S. is growing aging population and increasing demand for assisted care in a comfortable environment. Currently, there are over 40 million people in the U.S. alone aged 65 years & above and this number is anticipated to double by 2050. Rapidly growing geriatric population, which forms the key target population for DME, is anticipated to bolster the growth of the market over the forecast period. Furthermore, increasing prevalence of chronic diseases, growing technological advancements, and increasing government initiatives to improve healthcare are some other factors fueling the growth of this market. The rising geriatric population is expected to increase susceptibility toward chronic conditions such as diabetes, cardiovascular disorders, and other lifestyle disorders. With an ever-increasing prevalence of diseases and baby boomer population, healthcare expenditure levels are expected to continue to grow during the forecast period. The growth of home healthcare as a cost-effective alternative over hospital stay is expected to serve this market as a key driver over the forecast period.

U.S. DME Market
Get PDF
The key players in the market include Invacare Corporation, Sunrise Medical, ArjoHuntleigh, Hill Rom, Inc, Stryker Corporation, Medline Industries Inc., Drive Medical, GF Health Products Inc., and Carex Health Brands, Inc. among others.

Though many factors are driving the market growth, there are several issues that have a negative impact on the market. Failure to meet the desired performance is another vital reason why healthcare professionals hesitate from using DME, especially personal mobility devices. At times, while carrying obese patients, these equipment tend to break, which usually happens due to wear and tear. In such situations, the patient is at greater risk and prone to severe accidents and injuries. Also, DME are primarily used in the home healthcare settings and the fact that remuneration for home health & personal aides are significantly lower than other personal care & service workers and well below the median for all occupations discourages individuals to take up home health aide as a profession, which is expected to restrain market growth.  

The U.S. DME market is expected to witness a significant growth during the forecast period. Based on several government initiatives and insurance coverage, it is easy for the patients to use these equipment at a low cost. Both Medicare and Medicaid offer coverage for DME that are prescribed by the doctor for home use. Most DME can be purchased without prescription, however, some devices such as oxygen equipment require prescription. In addition, prescription becomes essential in case of reimbursement or the coverage.

For Further Insights and Segment-Specific Information, Contact a Market Analyst At : https://www.polarismarketresearch.com/industry-analysis/us-durable-medical-equipment-market/speak-to-analyst

Furthermore, numerous companies are launching technologically advanced systems to improve the usage and sales of DME. For instance, in August 2018 Somnoware, launched its enhanced durable medical equipment DME ordering capability for enterprise healthcare systems. Also, in May 2019 Breg, Inc., launched Breg Vision 7.0, in Apple’s app store, the next generation of its paperless workflow management system for orthopedic providers, to automates and optimizes in-house durable medical equipment (DME) programs. Such activities not only improves the existing technologies but also helps smoothen the purchase and usage process for the patients.
on No comments:
Labels: , ,

Prefilled Syringes Market 2020 Remarkable Growth Factors with Industry Size & Share, New Innovations of Leading Players

The global pre-filled syringes market size is expected to reach USD 10.1 billion by 2027 according to a new study by Polaris Market Research. The pharmaceutical industry is witnessing a rapid rise in bio-pharmaceuticals which is increasing demand for various advanced drug delivery devices, including prefilled syringes. Currently, more than 60% of the drugs in the clinical trials are biologics which needs to be administered parenterally.

Prefilled syringes (PFS) are efficient, reliable and convenient method for parenteral drug administration. These help the pharmaceutical companies to minimize drug waste and increase product life span which in turn leads to cost savings. PFS reduces the product wastage by preventing the dose overfill by four to five percent. This is especially advantageous for biological drugs as their manufacturing and product costs are too high and have low bulk manufacturing capacity. The product costs of some biologicals are as high as USD 2,000 per dose. PFS lowers the overall cost-per-dosage-unit compared to conventional syringe and vials. Hence, the demand for PFS is rising strongly in all customer segments; pharmaceutical companies, physicians and patients.


It is estimated that nearly 50% of the diabetics live in China, India, US, Brazil and Indonesia. There is immense scope for PFS market penetration in these emerging countries due to huge patient base. Many patients are choosing to self-administer drugs in non-medical settings to reduce their healthcare and other related treatment costs. Administering a PFS involves lesser steps and lesser dexterity in comparison to the conventional needle and syringe.  

PFS is convenient to use in non-medical settings as it is ergonomic, provide the accurate dose and preserves the sterility of the drug for over 6 months. PFS are increasingly being used for self-administration by users with chronic diseases such as diabetes and rheumatoid arthritis.

Market participants such as Becton Dickinson (BD), Medpro, Haselmeier AG, Stevanato Group, Owen Mumford, SCHOTT, Unilife Corporation, OMPI, Fresenius Kabi, Catalent, Vetter Pharma International GmbH, Gerresheimer, Weigao Corporation, West Pharmaceutical Services, Inc., and Nipro Medical Corporation are some of the key players operating in the concerned market.

For Further Insights and Segment-Specific Information, Contact a Market Analyst At : https://www.polarismarketresearch.com/industry-analysis/prefilled-syringes-market/speak-to-analyst

With surge in COVID-19 cases, the U.S. government is liable to increase domestic medical facility to cope up with the future scenario. In line with this, in May 2020, the Department of Defense (DOD) and the U.S. Department of Health and Human Services awarded a contract of worth USD 138 million to the U.S. based ApiJect Systems America to start Project Jumpstart. The project would revamp the country’s production capability, by October 2020, to be independent in manufacturing more than 100 million prefilled syringes, using blow-fill-seal aseptic plastic manufacturing technology.

on No comments:
Labels: , , ,

Tuesday, 21 July 2020

Platelet Aggregation Devices Market Analysis Focus On Business Economy With Innovative Growth Forecast 2027


The global platelet aggregation devices market size is expected to reach USD 1,556.8 million by 2027 according to a new study by Polaris Market Research. Platelet aggregation is the biological process where the platelet cells are employed in a process to prevent bleeding through vaso-constriction for rapid clot formation. The whole process is mediated via platelet aggregating factor (PAF). The quantitative and qualitative defects of platelets lead to increased bleeding. The high reactivity of platelets in the patients having anti-platelet therapy results in thromboembolic complications.

Platelet function related disorders can be either inherited or acquired. The inherited platelet function disorders include Von Willebrand disease, Glanzmann’s thrombasthenia, Bernard-Soulier syndrome, Storage pool disease. The acquired platelet dysfunction may be caused by chronic conditions such as kidney failure (uremia), Myelodysplastic syndrome (MDS), Leukemias (chronic myeloid leukemia or CML; acute myeloid leukemia or AML).


Platelet Aggregation Devices Market Size
Know more about this report: Get PDF Brochure

Some acquired platelet disorders are temporary because of the decreased function of platelets due to anti-platelet medications, non-steroidal anti-inflammatory drugs (NSAIDs), tricyclic antidepressants, antihistamines and some antibiotics. The platelet function testing is transitioned from diagnostics for heritable diseases to a functional one for platelet functional therapies. The rapid usage of anti-platelet therapy, mainly dual anti-platelet therapy has changed the focus of platelet function testing from diagnostics to therapeutics.
The market is driven by few notable factors such as the recent surge in infectious diseases (COVID-19) requiring rapid serological tests, innovations in platelet aggregation mechanisms, systems and consumables, and worldwide rise in chronic ailments. Specialized tests based on platelet aggregation include light transmission platelet aggregometry on platelet-rich plasma (LTA), impedance whole blood aggregometry (WBA), Lumi-aggregometry and flow cytometry.

Automated haematology analyzers can be used to obtain platelet counts over a wide range of values using optical counting methods like light scatter or fluorescence. Screening tests such as prothrombin time (PT) or activated partial thromboplastin time (aPTT) are more standardized and fully automated.


Number of reagents are available in the market to carry out the platelet function tests. These reagents include collagen, thrombin, ADP, vasopressin, epinephrine and ristocetin. Collagen, ADP were used in routine platelet aggregation studies for the evaluation of qualitative platelet function disorders.

Market participants such as F. Hoffmann La-Roche Ltd., Drucker Diagnostics, Haemonetics Corporation, Sysmex Corporation, Siemens Healthineers, Chrono-log Corporation, Instrumentation Laboratory, Accriva Diagnostics, Matis Medical, Helena Laboratories Corporation, Sienco, Inc., Bio/Data Corporation, Tem Group, WerfenLife, S.A., Laboratory Corporation of America Holdings, Sentinel CH. S.p.A., and Aggredyne, Inc. are some of the key players operating in the concerned market.

Have Questions? Or make an Inquiry before buying this report Speak to Our Industry Expert:  https://www.polarismarketresearch.com/industry-analysis/platelet-aggregation-devices-market/speak-to-analyst



on No comments:
Labels: , ,

IV Tubing Sets and Accessories Market Analysis, Segments, Major Geographies and Current Market Forecasts 2027


The global IV tubing sets and accessories market size is expected to reach USD 1,153.6 million by 2027 according to a new study by Polaris Market Research. I V tubing sets and accessories basically include different parts namely, infusion line, piercing needle, flow regulator, and luer connector attached with IV tube and the needle. These set are often known as intravenous therapy, designed to administer hydrating fluid, drug, medication directly into the circulatory system. Infusion supplies should be sterile disposable single time use products.

Most of the insulin pumps require infusion set to administer insulin into diabetic patients. Flexible tube connects pump reservoir, moving insulin from pump to needle beneath your skin. The selection of the infusion set often decided on the basis of pump compatibility with other accessories, needle insertion angle, gauge and length of cannula, and tube size.


IV Tubing Sets Market
Know more about this report : Get PDF Brochure 

European market saw a large set of these apparatus procured through group purchasing organizations in volumes at the reduced prices. In China, the market is expected to surpass Europe owing to dramatic entry of 800 million new people through its nationwide universal insurance system.

The global market is driven by a rise in chronic ailments such as cardiac disorders and diabetes, a sudden surge in infectious diseases, an increasing proportion of geriatrics using home-based infusion therapies. According to the International Diabetes Federation (IDF), the number of people suffering from diabetes were 415 million in 2015, which is expected to reach approximately 640 million by 2040.

Market participants such as Baxter International Inc., Becton, Dickinson and Company (CareFusion), Perfect Medical Ind. Co., Ltd, Hospira Inc. (Pfizer Inc.), B. Braun Melsungen AG, Smiths Medical, Fresenius Kabi, C.R. Bard, Inc., Zyno Medical, ICU Medical Inc., Nipro Corporation, Vygon, Poly Medicure, Health Line International Corporation, and Dynarex Corporation are some of the key players operating in the concerned market.

New and existing players are focusing on product innovation and new launches inclined towards dedicated therapy. The U.S. based medical start-up DiaTech Diabetic Technologies announced to launch SmartFusion technology based infusion set, which alerts diabetics with errors on real time basis. This has thumb sized fluid pressure sensing device for insulin pumps to monitor errors in the insulin delivery and sends signals to physicians through Bluetooth connection. According to the company’s claim globally, more than 120 million infusion sets are sold and it is estimated that around 60 per cent insulin pumps experience set failures, resulting in loss of USD 426 million of annual wastage from un-viable sites.

Have Questions? Or make an Inquiry before buying this report Speak to Our Industry Expert: https://www.polarismarketresearch.com/industry-analysis/iv-tubing-sets-accessories-market/speak-to-analyst

on No comments:
Labels: , , ,

Needle Free IV Connectors Market Latest Trends, Global Demand, Industry Growth,In-Depth Analysis And Opportunities Till 2027

The global needle-free IV connectors market size is expected to reach USD 1,647.7 million by 2027 according to a new study by Polaris Market Research. Needle free IV connectors (NFC) are small needleless devices used within intra-venous (IV) catheters, administration sets, and syringes. NFC is the basic medical supply present in any healthcare facility to administer fluid, drug or medication in different vascular access systems. These needle-free systems are designed with the purpose to reduce needle stick injuries, bacterial contamination in the blood to improve patient outcome.

The complications associated with the needle based connectors such as catheter based blood stream infections and the catheter lumen occlusion are acting as the drivers for the NFC market. The set of NFCs are coming up with superior designs and features to reduce the length of hospital stays and economic burden.


Needle-free IV Connector Market
Get PDF Brochure 

The prominent factors responsible for the growth of NFCs market the rising hospital admission rate, particularly among geriatrics, needle stick injuries among healthcare workers, and superior quality as compared to conventional systems. In 2016, the Center of Disease Control and Prevention (CDC) estimated more than 8.5 million people in the U.S have peripheral artery disease (PAD), out of which approximately 20% of the individuals were above age 60 years. The prevalence of the PAD is estimated equal among the men and women population. The primary reason behind the widespread of these diseases is less awareness among the population, especially in growing economies of the APAC region.

Market participants such as RyMed Technologies, LLC, Baxter International Inc., CareFusion Corporation, B. Braun Melsungen AG, Nexus Medical LLC, Becton, Dickinson and Company, ICU Medical, Inc., and Vygon S.A. are some of the key players operating in the concerned market. The factors such as superior designs, unique features, user friendliness with the healthcare workers, price, technology, and strong distribution in the geographical area are the competitive forces impacting the player presence in the area. The bigger companies are focusing on signing long term exclusive distribution agreement to remain dominant force in the market. In May 2019, B. Braun and Nexus Medical signed an agreement to distribute TKO-6P luer activated anti-reflux device. This will increase customer coverage with enhanced patient care for both the parties.

on No comments:
Labels: , , , ,

Human Microbiome Therapeutics Market Analysis Focus On Business Economy With Innovative Growth Forecast 2027

The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research. 
Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut. The human body comprises more than 100 trillion microbes and around 2 million microbe genomes. These microbiota plays a significant role in the body’s physiological functions and includes viruses, bacteria, and fungi. Primarily it has Bacteroidetes (gram negative) and Firmicutes, commonly Clostridium and Lactobacillus sp. (gram positive). The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.

Human Microbiome Therapeutics Market
Get PDF Brochure 
The global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects. In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research. The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.

Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I. du Pont de Nemours and Company, Finch Therapeutics, GNUbiotics Sciences, ClearB Therapeutics, GoodBelly, GoodGut, Synlogic, Second Genome, 16S Technologies, 5QBD-Biotech, Vedanta Biosciences, Holobiome, Commense, Ferring Pharmaceuticals, Evelo Biosciences, CoreBiome, Igen Biolab Group, ViThera Pharmaceuticals, DermBiont, Hyggut, Embion Technologies, Lactobio, BiomX, Exeliom Biosciences, and LNC Therapeutics are some of the key players operating in the concerned market.


Recently, in July 2020, 4D pharma plc., the UK based pharma company engaged in the development of live bio-therapeutics announced that patient enrollment for its phase II trial of its candidate oral immune-modulator MRx-4DP0004 for patients hospitalized with COVID-19 is open, and dosing to start very soon. The company is world leader in the production of live bio-therapeutics (live microbiome used to cure disease). Its products are the orally delivered single strain bacteria, which are naturally present in the human gut.
on No comments:
Labels: , , ,

Wearable Medical Devices Market 2020-2027 | In Depth Industry Analysis on Trends, Growth, Opportunities and Forecast

The global Wearable Medical Devices market size is expected to reach USD 85.6 billion by 2027 according to a new study by Polaris Market Research
Wearable medical devices are defined as the autonomous devices worn by the individual to provide medical or fitness monitoring and support over a period of time. They are either worn as a body accessory or being embedded in cloth or shoes. They incorporate non-invasive sensors, wireless transmission, real time data processing capabilities, and also provide medical feedback.

Recent developments in wearable medical devices include alert mechanisms, decision support systems, and real time analysis. These wearables offer point of care, and remote management for rehabilitating individuals, disabled and chronically ill.

  
Wearable Medical Device market
Get PDF Brochure 
The prominent factors favoring the wearable medical devices market growth include an increase in the prevalence of lifestyle-related diseases, consumer awareness towards fitness, and advancement in technology and medical innovation with ever increasing interest of consumer electronic companies. According to the study published by the International Diabetes Federation (IDF), in 2015, there were approximately 415 million diabetic people and it is expected to increase to 640 million by 2040. The high prevalence of diabetes is an important driver boosting market growth.

With a spike in infectious diseases over the past decade, the Stanford Healthcare Innovation Lab (SHIL) set up a team to study the impact of wearables to track infectious diseases. Moreover, in April 2020, Scripps Research Translational Institute (SRTI) launched DETECT, under which data from activity trackers and smart watches would be integrated into public health surveillance program for proactive disease tracking and population health programs.

Market participants such as Medtronic plc, OMRON Corp., Biotelemetry Inc., Apple, Inc., Koninklijke Philips, Dexcom Inc., Abbott Laboratories, Verily Life Sciences, GE Healthcare, Bio-Beat Technologies, Masimo Corporation, iRhythm Technologies, Inc., Preventice Solutions, Inc., CONTEC Medical Systems Co. Ltd, VitalConnect, Minttihealth, Biotricity Inc., Cyrcadia Asia Limited., Garmin Ltd, Xiaomi Technologies, ten3T healthcare, Fitbit, Inc., and Huawei Corporation are some of the key players operating in the Wearable Medical Devices market.


Players in the market are focusing on developing low cost wearable accessible to all strata of the population within the geographic footprint. In line with this, India based Muse Wearables is manufacturing a wrist based wearable tracker at a cost of INR 3,500. With this, it will continuously monitor skin temperature, blood O2 saturation levels, and heart rate to track body vital signs to diagnose COVID-19 symptoms in early stages. The device is Bluetooth enabled and could be connected via ‘Muse Health App’.



on No comments:
Labels: , , , ,

CT Scanner Market PESTEL Analysis, SWOT Study and Competitive Landscape Forecast 2027

The global CT Scanner market size is expected to reach USD 8.40 billion by 2027 according to a new study by Polaris Market Research. The report “CT Scanner Market Share, Size, Trends, Industry Analysis Report, By Type (Stationary and Portable CT Scanners); By Technology (High Slice, Mid Slice, Low Slice, and Cone Beam CT); By Architecture (C-arm and O-arm CT Scanners); By Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Other Applications), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Computed tomography is an imaging devices which enables users to look inside the specimen without cutting it. It utilizes computer systems and rotating X-rays machines to produce cross sectional images. In medical, it offers images of blood vessels, bones, and soft tissues to find any ailments or bone fractures in the human body. CT scanning is non-invasive, fast, accurate, and painless procedure. In emergency situation, it provides details of internal injuries and hemorrhage, which saves many human lives.


CT Scanner market
Get Sample Copy 
The prominent factors favoring the market growth include improvement in the Scanner technology, miniaturization resulting in portable CT Scanner, and rising prevalence in bone-related disorders coupled with road traffic accidents. According to the statistics published by the U.S. Center for Disease and Control (CDC), around 30 million people take part in sports related activities in the U.S. alone. Of this, individuals aged 15 to 20 accounted for around 2 million injuries and more than 30,000 hospital admissions per year.

Moreover, many start-ups are employing artificial intelligence (AI) for an accurate diagnosis. According to the study published in NVIDIA, AI could significantly drop error rate in cancer diagnosis by more than 85 per cent. In line with this, Aidoc, an Israel based start up is employing AI to decipher medical scans and in 2016, the U.S. based AI medical imaging platform Behold.ai, came up with its proprietary “red dot algorithm”. This algorithm has 90 per cent accuracy and faster scanning capability.


Market participants such as CurveBeam, Hitachi Medical Corporation, Neusoft, Samsung, Canon Medical Systems, GE Healthcare, Medtronic Inc., Accuray, Koning Corporation, Xoran, Koninklijke Philips, Carestream, Planmed Oy, Siemens Healthineers, Shenzhen Anke High-Tech, and United Imaging Technologies are some of the key players operating in the concerned market.

The players in the market are competing on different parameters such as strategic partnerships and agreements, exclusive service offerings, after-sales service, providing financing options, and warranties. In cost-sensitive untapped markets, the players are penetrating through government contracts, leasing and exclusive collaborations.



on No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)